Momenta Pharmaceuticals Slumps: MNTA Falls 16.9% in Session

Zacks

Momenta Pharmaceuticals Inc. (MNTA) saw a big move last session, as the company’s shares fell by nearly 17% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the most recent downtrend for MNTA as the stock is now down over 28% since March 19.

This biotechnology company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

Momenta Pharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.

Some better-ranked stocks in the same sector include Alkermes (ALKS), Alexion Pharmaceuticals, Inc. (ALXN) and Gilead Sciences Inc. (GILD). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



MOMENTA PHARMACEUTICALS INC (MNTA): Free Stock Analysis Report

ALKERMES PLC ORD (ALKS): Free Stock Analysis Report

ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)